CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 207 enrolled
Drug / intervention
Carbamazepine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00807989
NCT00807989Phase 4Completed
CompareCT.gov

An Open Label, Randomized, Multicenter Clinical Trial to Compare the Efficacy and Safety of Lamotrigine / Valproate Coadministration and Carbamazepine as Initial Pharmacotherapy in Epilepsies (Phase Ⅳ)

Yonsei University·interventional·Posted Dec 15, 2008·Updated Jul 27, 2015

In Brief

A Phase 4 clinical trial evaluating Carbamazepine and Lamotrigine/Valproate for Epilepsy. Completed, enrolled 207 participants across 1 site.

Detailed Summary

To evaluate the efficacy of usual monotherapy and low dose combination of Lamotrigine and Valproate. Low dose combination may be more effective and tolerable because they are low dose and VPA reduce Lamotrigine metabolism.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEpilepsy
CountriesSouth Korea
Collaborators--

Timeline

Phase 4CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedDec 15, 2008
Enrollment StartMar 1, 2008
Primary CompletionMay 1, 2012
TodayJul 2, 2026
Enrollment to primary: 4.2 yearsPosted 17.5 years ago

Interventions

Carbamazepinedrug

Lamotrigine/Valproatedrug